‹ Go back to overview

Total Market Analysis (Baseline and Endline) of Sexual Commodities (Condoms, sexual lubricants and other contraceptive products) in Suriname and Jamaica: free/generic, socially marketed and commercial brands

Suriname, Jamaica
Field of Expertise:
Medical Products/ TechnologiesPSCM /Financing and cost/pricingProcurement and Supply chain Assessments & Strengthening; Pharmaceutical markets (shaping, assessments, studies)
Narrative description of project:
The Caribbean has the highest regional HIV prevalence in the world outside sub-Saharan Africa. According to UNAIDS, the prevalence of HIV in Jamaica is estimated at 1.6% and in Suriname the estimated prevalence is 2.4% (2007).

CARICOM-KfW have contracted Options as the Regional consultant to support the implementation of the second phase of CARISMA, a social marketing programme for HIV prevention and the promotion of Reproductive Health in the Caribbean from 2009-2012. The programme will build upon innovative social marketing approaches used in the first phase of CARISME to create and expand the total market (public, commercial and social marketing distribution and sales) for condoms, other contraceptive products, and sexual lubricants in the region.

The overall objective of CARISMA 2 is to contribute to improving sexual and reproductive health in general and to the reduction of STI and HIV infection rates in particular in selected countries of the Caribbean.
Description of services provided:
The team carried out the following activities in Jamaica and Suriname:
1. Described the commercial segment of the market for condoms and other contraceptives (for Suriname) and the market for condoms and sexual lubricants (for Jamaica)
2. Described the social marketing segment of the market for condoms and other contraceptives (Jamaica: condoms and sexual lubricants)
3. Described the free segment of the condom market for condoms and other contraceptives/sexual lubricants
4. Estimated the total volume of condoms and other contraceptives/sexual lubricants sold/distributed (free, social marketing and commercial), broken down by contraceptive type
5. Discussed key limitations and biases in the data collated and collected for the study (e.g. problem of ‘suitcase trading’, lack of systematic data collection, reluctance of any distributors to share commercial information)
6. Identified key drivers and trends of the total contraceptive market, including future prospects (e.g. mass media campaigns, new initiatives, donations of condoms by international agencies, regional condom policy etc).
7. Made recommendations for a monitoring system to track the total contraceptive market in future based on strengths and limitations of the approach used.
8. In quarter 4 of 2012, repeated the study, updating the sales volumes and reporting on any significant changes in the market.

A dissemination event took place in Port of Spain, Trinidad & Tobago.